Skip to main navigation Skip to search Skip to main content

Correction to: Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas (Diabetes Therapy, (2021), 12, 8, (2115-2132), 10.1007/s13300-021-01059-1)

  • Yousef Al-Saleh
  • , Shaun Sabico
  • , Ahmed Al-Furqani
  • , Amin Jayyousi
  • , Dalal Alromaihi
  • , Ebtesam Ba-Essa
  • , Fatheya Alawadi
  • , Juma Alkaabi
  • , Mohamed Hassanein
  • , Saud Al-Sifri
  • , Seham Saleh
  • , Thamer Alessa
  • , Nasser M. Al-Daghri

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the Original Article, the author affiliations were incorrectly published. Please find the correct affiliations as given below. A.

Original languageEnglish
Pages (from-to)2265-2266
Number of pages2
JournalDiabetes Therapy
Volume12
Issue number8
DOIs
Publication statusPublished - Aug 2021

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'Correction to: Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas (Diabetes Therapy, (2021), 12, 8, (2115-2132), 10.1007/s13300-021-01059-1)'. Together they form a unique fingerprint.

Cite this